-
1
-
-
0041825261
-
Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease
-
Ahlemeyer B, Krieglstein J. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry 2003;36 (Suppl 1):S8-S14.
-
(2003)
Pharmacopsychiatry
, vol.36
, Issue.SUPPL. 1
-
-
Ahlemeyer, B.1
Krieglstein, J.2
-
2
-
-
4944263826
-
Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson' s disease
-
Kim MS, Lee JI, Lee WY, et al. Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson' s disease. Phytother Res 2004;18:663-666.
-
(2004)
Phytother. Res.
, vol.18
, pp. 663-666
-
-
Kim, M.S.1
Lee, J.I.2
Lee, W.Y.3
-
3
-
-
0347917012
-
Review about ginkgo biloba special extract EGb761 (Ginkgo)
-
Gertz HJ, Kiefer M. Review about ginkgo biloba special extract EGb761 (Ginkgo). Current Pharmaceutical Design 2004;10:261-264.
-
(2004)
Current Pharmaceutical Design
, vol.10
, pp. 261-264
-
-
Gertz, H.J.1
Kiefer, M.2
-
4
-
-
0041589131
-
Inhibition of glutamate-induced nitric oxide synthase activation by dopamine in cultured rat retinal neurons
-
Yamauchi T, Kashii S, Yasuyoshi H, et al. Inhibition of glutamate-induced nitric oxide synthase activation by dopamine in cultured rat retinal neurons. Neuroscience Letters 2003;347:155-158.
-
(2003)
Neuroscience Letters
, vol.347
, pp. 155-158
-
-
Yamauchi, T.1
Kashii, S.2
Yasuyoshi, H.3
-
6
-
-
0345120940
-
Measurement of mitochondrial membrane potential using fluoresent rhodamine derivatives
-
Scaduto RC Jr, Grotyohann LW. Measurement of mitochondrial membrane potential using fluoresent rhodamine derivatives. Biophs J 1999;76:469-477.
-
(1999)
Biophs. J.
, vol.76
, pp. 469-477
-
-
Scaduto Jr., R.C.1
Grotyohann, L.W.2
-
7
-
-
0031202689
-
Vitreous body glutamate concentration in dogs with glaucoma
-
Brooks DE, Garcia GA, Dreyer EB, et al. Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res 1997;58:864-867.
-
(1997)
Am. J. Vet. Res.
, vol.58
, pp. 864-867
-
-
Brooks, D.E.1
Garcia, G.A.2
Dreyer, E.B.3
-
8
-
-
0033062744
-
Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder
-
Dkhissi O, Chanut E, Wasowicz M, et al. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci 1999;40:990-995.
-
(1999)
Invest. Ophthalmol. Vis. Sci.
, vol.40
, pp. 990-995
-
-
Dkhissi, O.1
Chanut, E.2
Wasowicz, M.3
-
9
-
-
0029778159
-
Chronci low-dose glutamate is toxic to retinal ganglion cells: Toxicity blocked by memantine
-
Vorwerk CK, Lipton SA, Zurakowski D, et al. Chronci low-dose glutamate is toxic to retinal ganglion cells: toxicity blocked by memantine. Invest Ophthalmol Vis Sci 1996;37:1618-1624.
-
(1996)
Invest. Ophthalmol. Vis. Sci.
, vol.37
, pp. 1618-1624
-
-
Vorwerk, C.K.1
Lipton, S.A.2
Zurakowski, D.3
-
10
-
-
0033052291
-
Necrosis and apoptosis after retinal ischemia: Involvement of NMDA-mediated excitotoxicity and p53
-
Joo CK, Choi JS, Ko HW, et al. Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest Ophthalmol Vis Sci 1999;40:713-720.
-
(1999)
Invest. Ophthalmol. Vis. Sci.
, vol.40
, pp. 713-720
-
-
Joo, C.K.1
Choi, J.S.2
Ko, H.W.3
-
11
-
-
0031667887
-
Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia
-
Adachi K, Kashii S, Masai H, et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol 1998; 236:766-774.
-
(1998)
Graefes Arch. Clin. Exp. Ophthalmol.
, vol.236
, pp. 766-774
-
-
Adachi, K.1
Kashii, S.2
Masai, H.3
-
12
-
-
0033600277
-
The changing landscape of ischaemic brain injury mechanisms
-
Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 1999; 399:A7-A14.
-
(1999)
Nature
, vol.399
-
-
Lee, J.M.1
Zipfel, G.J.2
Choi, D.W.3
-
13
-
-
0032150860
-
Glutamate-induced neuron death requires mitochondrial calcium uptake
-
Stout AK, Raphael HM, Kanterewicz BI, et al. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci 1998;1:366-373.
-
(1998)
Nat. Neurosci.
, vol.1
, pp. 366-373
-
-
Stout, A.K.1
Raphael, H.M.2
Kanterewicz, B.I.3
-
14
-
-
0034307759
-
Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells
-
Ward MW, Rego AC, Frenguelli BG, et al. Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci 2000;20:7208-7219.
-
(2000)
J. Neurosci.
, vol.20
, pp. 7208-7219
-
-
Ward, M.W.1
Rego, A.C.2
Frenguelli, B.G.3
-
15
-
-
2242422533
-
Ginkgo biloba extract: From molecular mechanisms to the treatment of Alzhelmer' s disease
-
Zimmermann M, Colciaghi F, Cattabeni F, et al. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer' s disease. Cell Mol Biol (Noisy-le-grand) 2002;48:613-623.
-
(2002)
Cell Mol. Biol. (Noisy-le-grand)
, vol.48
, pp. 613-623
-
-
Zimmermann, M.1
Colciaghi, F.2
Cattabeni, F.3
-
16
-
-
0041825196
-
Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb761) in global brain ischemia and in excitotoxicity-induced neuronal death
-
Chandrasekaran K, Mehrabian Z, Spinnewyn B, et al. Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry 2003;36 (Suppl 1):S89S-S94.
-
(2003)
Pharmacopsychiatry
, vol.36
, Issue.SUPPL. 1
-
-
Chandrasekaran, K.1
Mehrabian, Z.2
Spinnewyn, B.3
-
17
-
-
0242467845
-
Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb761
-
Smith JV, Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb761. J Alzheimers Dis 2003; 5:287-300.
-
(2003)
J. Alzheimers Dis.
, vol.5
, pp. 287-300
-
-
Smith, J.V.1
Luo, Y.2
-
18
-
-
0031545460
-
Effect of the antioxidant action of Ginkgo biloba extract (EGb761) on aging and oxidative stress
-
Droy-Lefaix MT. Effect of the antioxidant action of Ginkgo biloba extract (EGb761) on aging and oxidative stress. Age 1997;20:141-149.
-
(1997)
Age
, vol.20
, pp. 141-149
-
-
Droy-Lefaix, M.T.1
-
19
-
-
0033580036
-
Ginkgo biloba extract (EGb761) protects NaK-ATPase activity during celebral ischemia in mice
-
Pierre S, Jamme I, Droy-Lefaix MT, et al. Ginkgo biloba extract (EGb761) protects NaK-ATPase activity during celebral ischemia in mice. NeuroReport 1999; 10:47-51.
-
(1999)
NeuroReport
, vol.10
, pp. 47-51
-
-
Pierre, S.1
Jamme, I.2
Droy-Lefaix, M.T.3
-
20
-
-
0031984178
-
A Ginkgo biloba extract (EGb761) prevents mitochondrial aging by protecting against oxidative stress
-
Sastre J, Millan A, de la Asuncion JG, et al. A Ginkgo biloba extract (EGb761) prevents mitochondrial aging by protecting against oxidative stress. Free Radic Biol Med 1998;24:298-304.
-
(1998)
Free Radic. Biol. Med.
, vol.24
, pp. 298-304
-
-
Sastre, J.1
Millan, A.2
de la Asuncion, J.G.3
|